Case Type: Mergers & Acquisitions

Regulus Therapeutics Inc. (NASDAQ: RGLS), relating to the proposed merger with Novartis AG. Under the terms of the agreement, Novartis will acquire Regulus for an initial payment of $7.00 per share, plus a non-tradeable CVR for $7.00 per share payable upon the achievement of a milestone in respect to regulatory approval.

GSR III Acquisition Corp. (NASDAQ: GSRT), relating to the proposed merger with Terra Innovatum Srl. Under the terms of the agreement, Terra Innovatum shareholders will roll 100% of their equity into the newly formed public entity.

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX), relating to the proposed merger with Merck KGaA, Darmstadt, Germany. Under the terms of the agreement, SpringWorks shareholders will receive $47.00 in cash per share of SpringWorks stock held.

Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP), relating to the proposed merger with Z Squared Inc. Under the terms of the agreement, holders of outstanding Z Squared shares will receive equity in Coeptis in exchange for 9,000 U.S. based dogecoin mining machines.

HarborOne Bancorp (NASDAQ: HONE), relating to the proposed merger with Eastern Bankshares, Inc. Under the terms of the agreement, shareholders of HarborOne will receive either 0.765 shares of Eastern common stock or $12.00 in cash, per share of HarborOne common stock.

Golden Ocean Group Limited (NASDAQ: GOGL), relating to the proposed merger with CMB.TECH NV. Under the terms of the agreement, Golden Ocean shareholders will receive 0.95 shares of CMB common stock per share of Golden Ocean common stock owned.

Pacific Premier Bancorp, Inc. (NASDAQ: PPBI), relating to the proposed merger with Columbia Banking System, Inc. Under the terms of the agreement, Pacific Premier stockholders will receive 0.9150 of a share of Columbia common stock for each Pacific Premier share they hold, and own approximately 30% of Columbia’s outstanding shares of common stock.

Columbia Banking System, Inc. (NASDAQ: COLB), relating to the proposed merger with Pacific Premier Bancorp, Inc. Under the terms of the agreement, Pacific Premier stockholders will be given 0.9150 of a share of Columbia common stock for each Pacific Premier share they own.

iCAD, Inc. (NASDAQ: ICAD), relating to the proposed merger with RadNet, Inc. Under the terms of the agreement, iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock held at the closing of the merger.

Longevity Health Holdings, Inc. (NASDAQ: XAGE), relating to the proposed merger with  20/20 BioLabs, Inc. Under the terms of the agreement, Longevity pre-merger stockholders are expected to own approximately 49.9% of the combined company.